Avita Medical Ltd (RCEL)

[Fmello]

Just read this from the Hot Copper forums:

* Highest commercials quarterly sales to date of US 7.45 million.
*Zero plans of capital raise or using debt but full intention of fund vitiligo and soft tissue market expansions using current cash to then become profitable
* With Japan sales later this year this will make current ONE income stream to FOUR income streams sometime in 2023.
* Very little money currently being allocated to genodermatoses and aesthetics - whilst proof of concept is exciting focus is on commercialisation of Vitiligo and Soft tissue as this is within immediate reach - the low handing and obvious fruit. For aesthetic use plan is to engage in partnership when the time comes to reduce cash burn and allow current funds to fulfil main pipeline objectives.
* Avita reps (majority ex burn nurses) now have unrestricted access to hospitals again this will drive further penetration and adoption for burns cases coming up to US summer months when %of burns increase from "camping" and related activities
* Trend is that ReCELL now being used for smaller Body Surface Area (BSA) burns - which is great shows useful trend prior to outpatient use (outpatient use will be lower TBSA burns)
* New RECELL ease of use means one person only required - this will launch in the coming months and likely to gather further momentum. It also fits nicely into outpatient treatments as solo operator very advantageous for adoption.
* The fully automated system being developed targeted at procedural dermatologists and it is likely to require a PMA supplement for equivalence of the cell suspension. Aim to complete around the time of Vitiligo launch or soon after.

AND THE MOST EXCITING INFORMATION TO ME WAS:
* AVITA Medical has been very active in attending multiple US and international vitiligo and dermatology conferences and there is a lot of enthusiasm generated around treating Vitiligo now that JAX inhibitors and ReCELL are complimentary treatments. JAX inhibitors = more patients with stable vitiligo. ReCELL = one treatment regimentation of lesions. Therefore a disease with previously very limited effective treatment options now has a new, convenient and cosmetically appealing solution that essentially offers "cure" ( ie the lesions have restored pigment (ReCELL) and the disease is dormant (JAX). )....yes I understand the definition of "cure" and this isn't scientifically a cure but its a moot point as patients will see it as one as they now look normal without areas of depigmentation.

Procedural dermatologists will be highly motivated to market ReCell for vitiligo as they will be doing the treatments and treatments is what they earn big money from. So opportunity and motivation all align here: patient, dermatologist, AVITA Medical and big Pharma developing JAX inhibitors
This = rapid adoption after approval and soon to become biggest sales arm of ReCELL